AbbVie Non-GAAP EPS of $3.37 Beats By $0.06, Revenue of $14.58B Misses By $60M, Cuts FY22 EPS Guidance

29
Comment
Favorite

AbbVie Non-GAAP EPS of $3.37 Beats By $0.06, Revenue of $14.58B Misses By $60M, Cuts FY22 EPS Guidance

Seeking Alpha2022-07-29

AbbVie Q2 Non-GAAP EPS of $3.37beats by $0.06.Revenue of $14.58B (+4.4% Y/Y)misses by $60M.Delivers Second-Quarter Net Revenues of $14.583 Billion, an Increase of 4.5 Percent on a Reported Basis and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Bspn
·2022-07-30
Ok
Reply
1
Report
eo1668
·2022-07-29
ok
Reply
Like
Report
chefbean
·2022-07-29
Woo
Reply
1
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1185459694?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-07-29 19:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185459694","market":"us","top_or_hot":-1,"title":"AbbVie Non-GAAP EPS of $3.37 Beats By $0.06, Revenue of $14.58B Misses By $60M, Cuts FY22 EPS Guidance","media":"Seeking Alpha","content":"<div>\n<p>AbbVie Q2 Non-GAAP EPS of $3.37beats by $0.06.Revenue of $14.58B (+4.4% Y/Y)misses by $60M.Delivers Second-Quarter Net Revenues of $14.583 Billion, an Increase of 4.5 Percent on a Reported Basis and ...</p>\n\n<a href=\"https://seekingalpha.com/news/3863083-abbvie-non-gaap-eps-of-337-beats-by-006-revenue-of-1458b-misses-by-60m-cuts-fy22-eps-guidance\">Source Link</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AbbVie Non-GAAP EPS of $3.37 Beats By $0.06, Revenue of $14.58B Misses By $60M, Cuts FY22 EPS Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAbbVie Non-GAAP EPS of $3.37 Beats By $0.06, Revenue of $14.58B Misses By $60M, Cuts FY22 EPS Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-29 19:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3863083-abbvie-non-gaap-eps-of-337-beats-by-006-revenue-of-1458b-misses-by-60m-cuts-fy22-eps-guidance><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AbbVie Q2 Non-GAAP EPS of $3.37beats by $0.06.Revenue of $14.58B (+4.4% Y/Y)misses by $60M.Delivers Second-Quarter Net Revenues of $14.583 Billion, an Increase of 4.5 Percent on a Reported Basis and ...</p>\n\n<a href=\"https://seekingalpha.com/news/3863083-abbvie-non-gaap-eps-of-337-beats-by-006-revenue-of-1458b-misses-by-60m-cuts-fy22-eps-guidance\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABBV","symbol_name":"艾伯维公司","start_time":0,"source_url":"https://seekingalpha.com/news/3863083-abbvie-non-gaap-eps-of-337-beats-by-006-revenue-of-1458b-misses-by-60m-cuts-fy22-eps-guidance","article_id":"1185459694","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185459694","pubTimestamp":1659095131,"sourceInfo":null,"weMediaInfo":null,"summary":"AbbVie Q2 Non-GAAP EPS of $3.37beats by $0.06.Revenue of $14.58B (+4.4% Y/Y)misses by $60M.Delivers ","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ABBV":"艾伯维公司"},"translate_title":"AbbVie非公认会计准则每股收益为3.37美元超过预期0.06美元营收为1458亿美元低于预期6000万美元下调22财年每股收益指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABBV":0.9},"content_text":"AbbVie Q2 Non-GAAP EPS of $3.37beats by $0.06.Revenue of $14.58B (+4.4% Y/Y)misses by $60M.Delivers Second-Quarter Net Revenues of $14.583 Billion, an Increase of 4.5 Percent on a Reported Basis and 6.1 Percent OperationallyShares -0.5%PM.Confirms 2022 Adjusted Diluted EPS Guidance Range of $13.78 - $13.98 from prior outlook of $13.92-$14.12 vs. $13.90 consensus, which Includes an Unfavorable Impact of $0.23 Per Share Related to Acquired IPR&D and Milestones Expense Incurred Year-To-Date Through the Second Quarter 2022","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":9901695630,"gmtCreate":1659178913920,"gmtModify":1676536269318,"author":{"id":"3582502134655895","authorId":"3582502134655895","name":"Bspn","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9901695630","repostId":1185459694,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9901058904,"gmtCreate":1659102660708,"gmtModify":1676536257868,"author":{"id":"3560376076037644","authorId":"3560376076037644","name":"eo1668","avatar":"https://static.tigerbbs.com/039a625a00fac8daa05bb87ff64ecd3c","vip":1,"crmLevel":6,"crmLevelSwitch":1},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9901058904","repostId":1185459694,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9901028893,"gmtCreate":1659101439312,"gmtModify":1676536257601,"author":{"id":"3554935180693279","authorId":"3554935180693279","name":"chefbean","avatar":"https://static.tigerbbs.com/75bcdd1d22221ef3b8f10c64b73ea420","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Woo","listText":"Woo","text":"Woo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9901028893","repostId":1185459694,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":29,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}